Post-approval studies (Phase 4)Study completedNCT00515021
What this trial is testing
Diurnal Variation of Plasminogen Activator Inhibitor-1
Who this might be right for
Metabolic Syndrome X
Vanderbilt University Medical Center 21
Showing 20 of 211 results